|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
Tap into NIH Funding
Several NIH program directors discuss current and future NIH funding opportunities relevant to pharmaceutical scientists, helping researchers to identify and negotiate the NIH programs right for them. They recommend doing your homework, finding the right NIH program, and establishing a relationship with the program director. Read more in the March 2016 AAPS Newsmagazine Online.
For a complete list of job postings, click here.
Have a job to post? Click here.
PHARMACEUTICAL CAREER NEWS
Learn To Read Between the Lines of a Job Ad
Most companies in the recruiting business are experiencing a great start to 2016. It appears that the job market is finally picking up a bit of steam, at least across the world of commerce and industry. There will always be a fair amount of stress and uncertainty for scientists looking for Ph.D.-level jobs, but I believe you’ll see more job ads today than you did a year ago.
Screening Enormous Databases To Find a Cure For Cancer
Developing new drugs is becoming increasingly difficult: research and lab experiments are time consuming and expensive. By making use of data first — screening large databases in order to discover patterns — we can make better predictions about what will work and what will not. This is what Gerard van Westen calls Data-Driven Drug Discovery. He received an NWO Veni grant for his current research, in which he uses data mining techniques to find a cure for cancer.
Zika On Our Doorstep
Medscape (free login required)
A new souvenir that no one wants may soon be making its way home with tourists after their beach vacations here: the Zika virus. The mosquito-borne virus is expected to plow through Puerto Rico with little to slow its spread. This island U.S. territory is $70 billion in debt, an amount its governor last year called “not payable.” Funding cuts have crippled public programs, leaving local health authorities shorthanded and without enough supplies.
In Development: New Generation of Superbug Drugs
New research published in the journal Nature reveals the mechanism by which drug-resistant bacterial cells maintain a defensive barrier. The findings pave the way for a new wave of drugs that kill superbugs by bringing down their defensive walls rather than attacking the bacteria itself. It means that in future, bacteria may not develop drug-resistance at all. Unravelling this mechanism could also help scientists understand more about human cell dysfunctions linked to disorders such as diabetes, Parkinson's and other neurodegenerative diseases.
The Jobs Tradeoffs in the TPP Trade Deal
Los Angeles Times
President Obama is trying to round up votes in Congress to ratify the Trans-Pacific Partnership before the end of his term. The White House has made approval of the 12-nation free-trade deal, which took seven years to negotiate, a top priority. But many in Congress and around the country have serious concerns about how it will affect everything from environmental regulations and drug prices to jobs and wages.
Public Health in an Era of Personalized Medicine
By Dr. Robert Carter
Collectively, the clinical medicine and public health communities have demonstrated to governments and their populations that public health programs and interventions are critical to reducing infectious and chronic diseases.
Furthermore, much of the success of public health interventions has been achieved with only a fraction of the public and private spending on clinical medical care. However, these investments by governments and private healthcare organizations are generally unrecognized by the public.
Big Pharma's Delicate Dance on Drug Prices
The Wall Street Journal
Drug makers are enjoying a research-and-development revival after a fallow period. Last year the U.S. Food and Drug Administration approved 45 new drugs, more than double the number in 2006.
But the industry also faces growing criticism of the prices it charges for new drugs — some cancer therapies cost as much as $150,000 a year — as well as repeated price increases for older drugs. Critics say high prices are putting drugs out of reach for many patients and straining healthcare budgets.
It's An Interview — Not An Interrogation
Old-school interviewers read questions from a script. They don’t know how to make a job interview a pleasant conversation. That’s too bad for them, the job applicants who have to suffer through their interviews, and the customers and shareholders who rely on their employers’ ability to snag great employees.
If you are someone who interviews job-seekers in your job, 2016 is the perfect time to throw out the interview script!
AAPS Career Services
Colby Horton, Vice President of Publishing, MultiBriefs, 469.420.2601
Download media kit
Jessica Taylor, Medical Editor, MultiBriefs, 202.684.7169
Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.
This edition of the AAPS Pharmaceutical Career News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Feb. 12, 2016
Jan. 8, 2016
Dec. 11, 2015
Nov. 13, 2015
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063